Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?

This book examines the use of compulsory licensing, a controversial TRIPS flexibility, by India and Brazil, focusing on the historical context, patent system, and multilateral organizations' philosophies. It is a valuable resource for intellectual property students, academics, policymakers, and lawyers, as well as those interested in international law, development, and public health.

Format: Hardback
Length: 184 pages
Publication date: 07 October 2021
Publisher: Springer Nature Switzerland AG

This comprehensive monograph delves into the intricate dynamics of India and Brazil's utilization of compulsory licensing, a highly contentious and significant TRIPS flexibility. Given the ongoing debate surrounding compulsory licensing and access to medicines in the wake of the COVID-19 pandemic, this work assumes heightened relevance. By examining the historical context and political frameworks of the patent system and compulsory licensing, the author offers valuable insights into the current situation.

The author conducts a thorough cross-national study, focusing on India and Brazil, to assess the diverse perspectives held by multilateral organizations such as the EU, the WIPO, the WTO, and NGOs regarding compulsory licensing. This analysis provides a comprehensive framework for understanding the complexities and nuances of this issue.

The book is of immense value to intellectual property students, academics, policymakers, and legal professionals engaged in the field. It also holds appeal to scholars specializing in international law, development, public health, and state actors involved in multilateral organizations. By shedding light on the historical, political, and legal aspects of compulsory licensing, this book contributes to a deeper understanding of this critical topic and its implications for global health and trade.

Weight: 393g
Dimension: 210 x 148 (mm)
ISBN-13: 9783030841928
Edition number: 1st ed. 2022